An update on bronchodilators in Phase I and II clinical trials

Erdheim Chester Disease: An Unusual Fluid Overload Mimic

(2012) Madan Joshi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes

(2012) Thys van der Molen et al.   Primary Care Respiratory Journal

Triple Therapy for the Management of COPD: A Review

(2011) Kathryn Gaebel et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Boehringer Ingleheim's selective glucocorticoid receptor agonist development candidate: evaluation of WO2010141331, WO2010141332 and WO2010141333

(2011) Peter Norman   EXPERT OPINION ON THERAPEUTIC PATENTS

Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial

(2011) Huib A.M. Kerstjens et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Safety of long-acting β agonists for the treatment of asthma: clearing the air

(2011) Gustavo J Rodrigo et al.   THORAX

Novel bronchodilators for the treatment of chronic obstructive pulmonary disease

(2011) Maria Gabriella Matera et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease

(2010) Kai M. Beeh et al.   ADVANCES IN THERAPY

Symptom variability in patients with severe COPD: a pan-European cross-sectional study

(2010) R. Kessler et al.   EUROPEAN RESPIRATORY JOURNAL

Long-Term Safety of Mometasone Furoate/Formoterol Combination for Treatment of Patients with Persistent Asthma

(2010) Jorge F. Maspero et al.   JOURNAL OF ASTHMA

THRX-198321 Is a Bifunctional Muscarinic Receptor Antagonist and  2-Adrenoceptor Agonist (MABA) That Binds in a Bimodal and Multivalent Manner

(2010) T. Steinfeld et al.   MOLECULAR PHARMACOLOGY

The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma

(2010) Badrul A. Chowdhury et al.   NEW ENGLAND JOURNAL OF MEDICINE

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

(2010) John R. Hurst et al.   NEW ENGLAND JOURNAL OF MEDICINE

The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD

(2010) Mario Cazzola et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs

(2010) Edmond L. Toy et al.   RESPIRATORY MEDICINE

P137 Efficacy and safety of once-daily aclidinium bromide 200  g in combination with formoterol in patients with COPD

(2010) P. Sliwinski et al.   THORAX

Novel bronchodilators in asthma

(2009) Mario Cazzola et al.   CURRENT OPINION IN PULMONARY MEDICINE

Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future

(2009) Kian Fan Chung et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Emerging inhaled bronchodilators: an update

(2009) M. Cazzola et al.   EUROPEAN RESPIRATORY JOURNAL

From the authors:

(2009) P-O. Bridevaux et al.   EUROPEAN RESPIRATORY JOURNAL

MDR-TB and XDR-TB: drug resistance and treatment outcomes

(2009) G. B. Migliori et al.   EUROPEAN RESPIRATORY JOURNAL

Novel long-acting bronchodilators for COPD and asthma

(2008) M Cazzola et al.   BRITISH JOURNAL OF PHARMACOLOGY

Global strategy for asthma management and prevention: GINA executive summary

(2008) E. D. Bateman et al.   EUROPEAN RESPIRATORY JOURNAL